Bexarotene Capsules
Dosage form: capsule, liquid filled
Drug class:Miscellaneous antineoplastics
Medically reviewed by Drugs.com. Last updated on May 1, 2021.
On This Page
- Boxed Warning
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
Bexarotene is a member of the retinoid class of drugs that is associated with birth defects in humans. Bexarotene also caused birth defects when administered orally to pregnant rats.Bexarotene Capsules must not be administered to a pregnant woman. (8.1)
Indications and Usage for Bexarotene Capsules
Bexarotene Capsules are indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.
Bexarotene Capsules Dosage and Administration
The recommended initial dose of Bexarotene Capsules is 300 mg/m2/day (see Table 1). Bexarotene Capsules should be taken as a single oral daily dose with a meal. For precautions to prevent pregnancy and birth defects in women of child-bearing potential [see Use in Specific Populations (8.1)].
Initial Dose Level (300 mg/m2/day) | ||
MEDICAL DEPARTMENTS
Cardiology
Pediatrics
Diabetes Care
Pre-natal Care
Ultrasound Echocardiogram
| ||
